2-BROMO-4-(2-HYDROXYETHYL)-5-METHYLTHIAZOLE, 95.0%, 250mg

[S(R)]-N-[(S)-[3,5-Di-tert-butyl-4-methoxyphenyl][(3-benzyloxy-2-(dicyclohexylphosphino)phenyl)methyl]-2-methyl-2-propanesulfinamide, 95%, 100mg

3,3,3',3'-Tetramethyl-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-6,6'-diol, 95.0%, 5g

4-chloro-1-methyl-1H-indole-2-carboxylic acid, 95.0%, 100mg

Benzyl 2-bromoethyl ether, 97.0%, 25g

1-Benzyl-4,4-difluoropiperidine, 95.0%, 100g

1,1'-[(1,1-Dimethylethyl)[[(1S)-1-methyl-2-propyn-1-yl]oxy]silylene]bis[benzene], 95%, 1g

7-BROMO-5-CHLORO-INDAN-1-ONE, 95%, 100mg

Cu-TMEDA catalyst, 97%, 1g

1H-Pyrrole-2,5-dicarbaldehyde, 95%, 100mg

1,2-Bis(1,1,2,2-tetrafluoroethoxy)benzene, 97.0%, 10g

3-Bromo-5-chlorothiophene-2-carboxylic acid, 95.0%, 100mg

4-Bromo-2-methyl-2H-indazole, 95.0%, 10g